Aigen Investment Management, LP Sangamo Therapeutics, Inc Transaction History

Aigen Investment Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$4.27 - $6.39 $53,703 - $80,367	12,577 New	12,577 $62,000
Q1 2022 May 05, 2022	SELL	$5.23 - $7.82 $71,447 - $106,829	-13,661 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$7.29 - $10.97 $99,588 - $149,861	13,661 New	13,661 $113,000
Q4 2020 Feb 12, 2021	SELL	$9.23 - $18.18 $316,487 - $623,374	-34,289 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$9.38 - $12.48 $321,630 - $427,926	34,289 New	34,289 $324,000

111

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $180M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.